It seems to me, that every time you guys argue about p-values, and OBF, and what statistical this or that the company is using, its generally a negative outcome. Am I wrong? If the drug really worked well, it shouldnt really be this difficult. IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.